Hikma Pharmaceuticals Usa Inc. 401(k) Retirement Plan
Sponsored by Hikma Pharmaceuticals Usa Inc. · EIN 223114571 · Plan #002
- Total assets
- $275M
- Net assets
- $275M
- Active participants
- 2,237
- With balances
- 2,547
Plan year beginning 01/01/2024 · 401(k)
Linked investment advisers
Advisory firms matched from Schedule C service providers (investment codes 26-28).
No linked investment advisers.
Service providers
Schedule C providers paid $5,000+ (large plans only).
| Provider | Services | Direct comp |
|---|---|---|
| Merrill Lynch, Pierce, Fenner And S | Recordkeeping, Shareholder servicing fees, Sub-transfer agency fees | $217,058 |
| Fidelity Investments Institutional | Participant loan processing, Sub-transfer agency fees, Recordkeeping fees | $27,017 |